X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

IMNM

Closed

Immunome inc

8.465
-0.835 (-8.98%)
Last Update: 01 Jul 2025 23:09:00
Yesterday: 9.3
Day's Range: 8.46 - 9.3423
Send
When Written:
 
4.79
Immunome Inc is a biotechnology company that focuses on developing and commercializing antibody-based therapeutics for infectious diseases, including COVID-19. The company uses its proprietary discovery platform, called IMM-01, which leverages the immune system of convalescent patients to identify and isolate therapeutic antibodies. Immunome's lead product candidate, IMM-BCP-01, is a cocktail of three monoclonal antibodies that target the SARS-CoV-2 virus and is currently in Phase 2 clinical trials. The company is also developing therapies for other infectious diseases, such as influenza and Zika virus. Immunome Inc was founded in 2015 and is headquartered in Philadelphia, Pennsylvania.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.209
X